港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

抗疫概念

878.387

-5.729-0.65%

涨家数：5

跌家数：12

平家数：- -

市盈率：- -

高：884.415

开：884.196

低：862.733

收：884.117

成交量：1.57亿

成交额：12.06亿

市值：5,944.70亿

流通市值：4,913.93亿

数据加载中...

总览新闻资讯

【湾区早参】香港6月平均工资率较上年同期上升3.4%；2025年深圳体育消费规模达766.59亿元

歌礼制药-B宣布：同类首创及同类最佳口服小分子IL-17A抑制剂ASC50治疗斑块状银屑病美国28天概念验证临床研究获积极结果

歌礼制药-B(01672)宣布同类首创和同类最佳的口服小分子IL-17A抑制剂ASC50治疗斑块状银屑病在美国的28天概念验证临床研究取得积极结果

智通财经网

上海思璞锐医药与默沙东达成全球独家授权首付款4亿美元

再次突围！药ETF华宝（562050）标的指数逆市收红，器械巨头力挺，512170韧劲十足！医药抗跌力从何而来？

石药集团(01093.HK)：SYS 6077注射液在中国获临床试验批准

甘肃农垦药物碱厂与广州安信医药有限公司座谈交流

劲方医药-B(02595)9月28日斥资318.55万港元回购11.6万股

中生制药(01177.HK)与STADA达成生物类似药战略合作里程碑付款高达4.7亿元

阿斯达克财经

中国生物制药(01177.HK)附属与STADA就生物类似药达成战略合作

中国生物制药：Stada将在授权区域持有上市许可与销售权，并拥有美国及海湾合作委员会市场选择权

中国生物制药：正大天晴授予Stada帕博利珠单抗生物类似药在欧盟、瑞士、英国及独联体的独家许可

劲方医药－Ｂ(02595)股价下跌8.027%，现价港币$27.5

阿斯达克财经

医药股普涨的内外部逻辑

国际金融报

医药韧性凸显！药ETF华宝（562050）逆市飘红，丽珠集团涨停！医疗器械局部强势，迈瑞、联影携手走强

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/BK1515/news?page=9"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":878.38727,"timestamp":1791872994083,"preClose":884.1166,"halted":0,"volume":157367521,"delay":0,"changeRate":-0.00648,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-5.729309,"latestTime":"10-13 14:29:55","open":884.1956,"high":884.4146,"low":862.7329,"amount":1205911319,"amplitude":0.024524,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791879000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791855000000,1791864000000],[1791867600000,1791878400000]],"pbRate":1.340867,"peRate":17.376399,"turnoverRate":0.002156,"increases":5,"decrements":12,"flats":0,"marketCap":594470145216,"floatMarketCap":491393280576},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":884.4146,"amplitude":0.024524,"preClose":884.1166,"low":862.7329,"pbRate":"1.340867","latestPrice":878.38727,"volume":157367521,"delay":0,"open":884.1956,"prevYearClose":1190.107,"prevWeekClose":890.643,"prevMonthClose":925.469,"prevQuarterClose":925.469,"fiveDayClose":924.393,"twentyDayClose":888.076,"sixtyDayClose":922.819,"secType":"PLATE","market":"HK","turnoverRate":0.002156,"peRate":17.376399,"marketCap":594470145216,"floatMarketCap":491393280576,"timestamp":1791872994083,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":5,"down":12,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671266418","title":"【湾区早参】香港6月平均工资率较上年同期上升3.4%；2025年深圳体育消费规模达766.59亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671266418","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671266418?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 08:26","pubTimestamp":1790641607,"startTime":"0","endTime":"0","summary":"2、香港6月的平均工资率较上年同期上升3.4%根据香港政府统计处9月28日公布的数字，在统计调查中包括的所有选定行业主类，以名义工资指数计算，2026年6月的平均工资率较上年同期上升3.4%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992667","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03143","BK1560","LU0307460666.USD","LU1961090484.USD","LU0348825331.USD","BK1589","HK0001040168.HKD","BK1515","HK0000286598.CNH","LU0561508036.HKD","LU2399975544.HKD","LU0540923850.HKD","LU1831875114.USD","LU0149721374.USD","LU0463099449.HKD","LU0370786039.SGD","02238","LU0348784397.USD","02883","LU0149534421.HKD","02635","LU0348783233.USD","SG9999006597.SGD","LU1023057109.AUD","IE00BZ08YR35.GBP","LU0039217434.USD","LU0417516738.SGD","LU0417516902.SGD","SG9999001069.SGD","LU1282651048.USD","LU0173614495.USD","LU0737861699.HKD","LU1880383366.USD","01177","LU1794554557.SGD","LU1188198961.HKD","IE00BZ08YS42.EUR","01398","HK0000165453.HKD","LU1880383440.USD","LU0072913022.USD","LU0326950275.SGD","BK1505","LU0164865239.USD","LU0348827113.USD","IE00BZ08YT58.USD","SG9999013353.USD","LU0634319403.HKD","LU0417516571.SGD","LU1497733557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150056399","title":"歌礼制药-B宣布：同类首创及同类最佳口服小分子IL-17A抑制剂ASC50治疗斑块状银屑病美国28天概念验证临床研究获积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1150056399","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150056399?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 08:04","pubTimestamp":1790640246,"startTime":"0","endTime":"0","summary":"歌礼制药-B宣布，其用于治疗斑块状银屑病的候选药物ASC50——一款同类首创且具备同类最佳潜力的口服小分子IL-17A抑制剂——在美国开展的28天概念验证临床研究中取得积极结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","BK1574","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671652022","title":"歌礼制药-B(01672)宣布同类首创和同类最佳的口服小分子IL-17A抑制剂ASC50治疗斑块状银屑病在美国的28天概念验证临床研究取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2671652022","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671652022?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 07:56","pubTimestamp":1790639809,"startTime":"0","endTime":"0","summary":"歌礼制药-B(01672)公布，ASC50在美国轻度至中度斑块状银屑病患者中开展的一项随机、双盲、安慰剂对照的28天概念验证临床试验取得积极结果。该I期研究旨在评估每日一次200毫克ASC50在轻度至中度斑块状银屑病患者中治疗28天后的安全性、疗效和药代动力学(NCT07024602)。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg17.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg17.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501805.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","BK1161","01672","BK1574","BK1515","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670232287","title":"上海思璞锐医药与默沙东达成全球独家授权 首付款4亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232287","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670232287?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 19:59","pubTimestamp":1790596779,"startTime":"0","endTime":"0","summary":"【上海思璞锐医药与默沙东达成全球独家授权 首付款4亿美元】9月28日，上海思璞锐医药科技有限公司（SciBrunch Therapeutics Co., Ltd.，以下简称“思璞锐”）与默沙东（默沙东为美国新泽西州罗威市默克公司的公司商号）共同宣布，双方就在研口服KRAS G12D（ON）抑制剂SPR2015达成全球独家授权协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609283885360447.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609283885360447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09939","BK1574","BK1161","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670344192","title":"再次突围！药ETF华宝（562050）标的指数逆市收红，器械巨头力挺，512170韧劲十足！医药抗跌力从何而来？","url":"https://stock-news.laohu8.com/highlight/detail?id=2670344192","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670344192?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 19:46","pubTimestamp":1790595960,"startTime":"0","endTime":"0","summary":"医疗ETF华宝跟踪的中证医疗指数微跌0.14%。截至收盘，药ETF华宝、医疗ETF华宝标的指数市盈率TTM分别为29.12倍、30.46倍，位于近10年10.86%、25.44%分位点，估值水平处于历史相对低位。药ETF华宝、医疗ETF华宝基金经理张放指出，医药投资主线或正从前期的“低估修复”，转向“创新兑现”驱动，同时AIDD产业链提供新增结构性机会。医疗ETF华宝：医药医疗类ETF旗舰，二季报规模256.24亿元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-28/doc-initktpc3633274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","09939","562050","512170","BK1515","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236373","title":"石药集团(01093.HK)：SYS 6077注射液在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236373","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236373?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 18:11","pubTimestamp":1790590293,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1951186391.HKD","LU0501845795.SGD","IE00B5MMRT66.SGD","LU1152091754.HKD","LU0072913022.USD","BK1521","IE00BZ08YS42.EUR","LU2039709279.SGD","LU0067412154.USD","01093","IE00BZ08YR35.GBP","LU0140636845.USD","LU1993786604.SGD","IE00BZ08YT58.USD","LU0326950275.SGD","BK1191","LU1226288170.HKD","LU1008478684.HKD","LU1813983027.USD","LU1328277881.USD","LU1226287875.USD","IE0008368742.USD","LU1226287792.SGD","LU1152091168.USD","LU1226287529.USD","BK1515","KURE","LU0880133367.SGD","LU1807302812.USD","LU0315179316.USD","IE00B031HY20.USD","LU1960683339.HKD","HK0000165453.HKD","LU0314109678.HKD","IE0008369823.USD","LU1226288253.USD","SG9999004220.SGD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670823999","title":"甘肃农垦药物碱厂与广州安信医药有限公司座谈交流","url":"https://stock-news.laohu8.com/highlight/detail?id=2670823999","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670823999?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 18:09","pubTimestamp":1790590140,"startTime":"0","endTime":"0","summary":"近日，广州安信医药有限公司核心研发团队到药物碱厂有限公司开展实地参观并座谈交流。公司领导班子及研发、注册、生产相关项目负责人和技术人员参加座谈。本次面对面深度交流，有效打通了上下游信息壁垒，进一步了解掌握了全国麻精药品市场信息，明确了公司在全球麻精药品市场定位，开拓了今后发展思路和方向。广州安信医药对药物碱厂在原料药领域的研发实力与合规体系给予充分肯定。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-28/doc-initktnz9654871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","09939","BK1161","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670235916","title":"劲方医药-B(02595)9月28日斥资318.55万港元回购11.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670235916","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670235916?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 17:53","pubTimestamp":1790589238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B(02595)发布公告，于2026年9月28日斥资318.55万港元回购11.6万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1515","BK1574","159938","02595","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670238483","title":"中生制药(01177.HK)与STADA达成生物类似药战略合作 里程碑付款高达4.7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670238483","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670238483?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 16:59","pubTimestamp":1790585940,"startTime":"0","endTime":"0","summary":"中国生物制药公布，附属公司正大天晴药业集团与STADA Arzneimittel AG就生物类似药达成战略合作，双方将携手提升生物类似药在全球多个地区的患者可及性。此外，STADA亦享有选择权，可新增最多三款其他生物类似药分子，覆盖肿瘤及免疫领域。中生制药表示，年初至今已达成多项对外授权交易，合计首付款及近期里程碑付款达3.55亿美元，潜在总交易金额达34亿美元。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220728114525438_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220728114525438_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1546740/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1546740/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1589","BK1515","01477","BK1521","BK1574","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","HK0000165453.HKD","IE00BZ08YR35.GBP","01177","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670850238","title":"中国生物制药(01177.HK)附属与STADA就生物类似药达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2670850238","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670850238?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 16:49","pubTimestamp":1790585397,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01177","BK1521","BK1191","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1589","HK0000165453.HKD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108731528","title":"中国生物制药：Stada将在授权区域持有上市许可与销售权，并拥有美国及海湾合作委员会市场选择权","url":"https://stock-news.laohu8.com/highlight/detail?id=1108731528","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108731528?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 16:48","pubTimestamp":1790585331,"startTime":"0","endTime":"0","summary":"中国生物制药：Stada将在授权区域持有上市许可与销售权，并拥有美国及海湾合作委员会市场选择权","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","01177","BK1589","BK1521","IE00BZ08YT58.USD","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1191","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151613908","title":"中国生物制药：正大天晴授予Stada帕博利珠单抗生物类似药在欧盟、瑞士、英国及独联体的独家许可","url":"https://stock-news.laohu8.com/highlight/detail?id=1151613908","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151613908?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 16:48","pubTimestamp":1790585307,"startTime":"0","endTime":"0","summary":"中国生物制药宣布，旗下正大天晴已就帕博利珠单抗生物类似药与Stada达成授权协议，授予后者在欧盟、瑞士、英国以及独联体地区的独家许可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","01177","BK1589","IE00BZ08YR35.GBP","BK1191","IE00BZ08YT58.USD","BK1521","HK0000165453.HKD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670842862","title":"劲方医药－Ｂ(02595)股价下跌8.027%，现价港币$27.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2670842862","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670842862?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 15:09","pubTimestamp":1790579340,"startTime":"0","endTime":"0","summary":"[下跌股]劲方医药－Ｂ(02595) 股价在下午03:08比前收市价下跌8.027%，现股价为港币$27.5。至目前为止，今日最高价为$29.98，而最低价为$27.5。总成交量为330.694万股，总成交金额为港币$9.399千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609282651/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609282651/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1574","09939","BK1515","02595","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670281855","title":"医药股普涨的内外部逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2670281855","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670281855?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 14:13","pubTimestamp":1790576024,"startTime":"0","endTime":"0","summary":"9月21日，A股医药板块迎来久违的全线爆发，华仁药业、透景生命、近岸蛋白等21只个股涨停，板块内超460只个股收涨，药明康德、恒瑞医药、荣昌生物等行业龙头同步大幅拉升。截至当日收盘，医药指数收涨3.2%，细分赛道全线爆发，基因测序板块大涨4.9%，创新药板块涨4.6%，CRO（合同研究组织）板块涨4.2%，港股创新药ETF（交易型开放式指数基金）更是大涨6%，领涨全市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609283885143089.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609283885143089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","09939","BK1574","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670286537","title":"医药韧性凸显！药ETF华宝（562050）逆市飘红，丽珠集团涨停！医疗器械局部强势，迈瑞、联影携手走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2670286537","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670286537?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 13:11","pubTimestamp":1790572260,"startTime":"0","endTime":"0","summary":"制药板块顽强抗跌，场内唯一跟踪制药指数的药ETF华宝一度逆市飘红，创新药概念股丽珠集团涨停封板，健康元、康弘药业、普洛药业齐涨逾5%。把握超跌医药新机遇，投资工具关注：药ETF华宝：全市场唯一跟踪制药指数的ETF，“70%创新药+20%中药”独家配比，兼具创新药高成长及中药高股息。医疗ETF华宝：全市场医药医疗类ETF旗舰，Q2规模256.24亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-28/doc-initkarm3859610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LGHT","09996","BK1515","09939","HART","MDEV","AGNG","MEDX","IEIH","000513","BK0239","GDOC","BK1574","BK0028","159883","BK0188","LNGR","PTH","BK1583","562050","BK1161","BK0187","BK1100","RSPH","159938"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":9,"totalSize":175,"code":"91000000","status":"200"}]}}